676560-66-0 Usage
Uses
Used in Pharmaceutical Industry:
2-Pyrrolidinecarbonitrile, 5-ethynyl-1-[[[2-(4-fluorophenyl)-1,1-dimethylethyl]amino]acetyl]-, (2S,5R)is used as a potential pharmacological agent for the development of new drugs targeting neurological or psychiatric disorders. Its unique structure and the presence of various functional groups may allow it to interact with specific enzymes or proteins in biological systems, offering a new avenue for therapeutic intervention.
Used in Research and Development:
In the field of medicinal chemistry, 2-Pyrrolidinecarbonitrile, 5-ethynyl-1-[[[2-(4-fluorophenyl)-1,1-dimethylethyl]amino]acetyl]-, (2S,5R)serves as a valuable compound for research and development. Its synthesis and modification can provide insights into the structure-activity relationships of potential drug candidates, contributing to the advancement of drug discovery and design.
Check Digit Verification of cas no
The CAS Registry Mumber 676560-66-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,6,5,6 and 0 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 676560-66:
(8*6)+(7*7)+(6*6)+(5*5)+(4*6)+(3*0)+(2*6)+(1*6)=200
200 % 10 = 0
So 676560-66-0 is a valid CAS Registry Number.
676560-66-0Relevant academic research and scientific papers
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
-
, (2008/06/13)
The present invention relates to compounds that inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclero
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
-
, (2008/06/13)
The present invention relates to compounds which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atheroscler
PHARMACEUTICAL COMPOSITIONS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV)
-
Page 87, (2010/11/30)
The present invention relates to compounds which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases.
